Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-pjpqr Total loading time: 0 Render date: 2024-06-28T14:41:01.749Z Has data issue: false hasContentIssue false

Chapter 68 - Moyamoya Disease

from Section 7 - Non-Inflammatory Disorders of the Arterial Wall

Published online by Cambridge University Press:  15 June 2018

By
Jong S. Kim ,
Oh Young Bang  and
Chang Wan Oh
Edited by
Louis Caplan  and
José Biller
Louis Caplan
Affiliation:
Beth Israel-Deaconess Medical Center, Boston
José Biller
Affiliation:
Loyola University Stritch School of Medicine, Chicago
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Uncommon Causes of Stroke , pp. 545 - 559
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Suzuki, J, Takaku, A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288–99.CrossRefGoogle ScholarPubMed
Hayashi, K, Horie, N, Izumo, T, Nagata, I. A nationwide survey on unilateral moyamoya disease in Japan. Clin Neurol Neurosurg. 2014;124:1–5.CrossRefGoogle ScholarPubMed
Kuroda, S, Ishikawa, T, Houkin, K, et al. Incidence and clinical features of disease progression in adult moyamoya disease. Stroke. 2005;36:2148–53.Google Scholar
Natori, Y, Ikezaki, K, Matsushima, T, Fukui, M. “Angiographic moyamoya”: Its definition, classification, and therapy. Clin Neurol Neurosurg. 1997;99:S168–72.Google Scholar
Wakai, K, Tamakoshi, A, Ikezaki, K, et al. Epidemiological features of moyamoya disease in Japan: Findings from a nationwide survey. Clin Neurol Neurosurg. 1997;99 Suppl 2:S1–5.Google Scholar
Kuriyama, S, Kusaka, Y, Fujimura, M, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: Findings from a nationwide epidemiological survey. Stroke. 2008;39:42–7.Google Scholar
Baba, T, Houkin, K, Kuroda, S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry. 2008;79:900–4.Google Scholar
Im, SH, Cho, CB, Joo, WI, et al. Prevalence and epidemiological features of moyamoya disease in Korea. J Cerebrovasc Endovasc Neurosurg. 2012;14:75–8.Google Scholar
Ahn, IM, Park, DH, Hann, HJ, et al. Incidence, prevalence, and survival of moyamoya disease in Korea: A nationwide, population-based study. Stroke. 2014;45:1090–5.Google Scholar
Chen, PC, Yang, SH, Chien, KL, Tsai, IJ, Kuo, MF. Epidemiology of moyamoya disease in Taiwan: A nationwide population-based study. Stroke. 2014;45:1258–63.Google Scholar
Miao, W, Zhao, PL, Zhang, YS, Liu, HY, Chang, Y, Ma, J, et al. Epidemiological and clinical features of moyamoya disease in Nanjing, China. Clin Neurol Neurosurg. 2010;112:199–203.Google Scholar
Duan, L, Bao, XY, Yang, WZ et al. Moyamoya disease in China: Its clinical features and outcomes. Stroke. 2012;43:56–60.Google Scholar
Cho, WS, Kim, JE, Kim, CH, et al. Long-term outcomes after combined revascularization surgery in adult moyamoya disease. Stroke. 2014;45:3025–31.Google Scholar
Jo, KI, Yeon, JY, Hong, SC, Kim, JS. Clinical course of asymptomatic adult moyamoya disease. Cerebrovasc Dis. 2014;37:94–101.Google Scholar
Cho, WS, Chung, YS, Kim, JE, et al. The natural clinical course of hemodynamically stable adult moyamoya disease. J Neurosurg. 2015;122:82–9.Google Scholar
Han, C, Feng, H, Han, YQ, et al. Prospective screening of family members with moyamoya disease patients. PLoS One. 2014;9:e88765.CrossRefGoogle ScholarPubMed
Uchino, K, Johnston, SC, Becker, KJ, Tirschwell, DL. Moyamoya disease in Washington State and California. Neurology. 2005;65:956–8.Google Scholar
Kainth, D, Chaudhry, SA, Kainth, H, Suri, FK, Qureshi, AI. Epidemiological and clinical features of moyamoya disease in the USA. Neuroepidemiology. 2013;40:282–7.CrossRefGoogle ScholarPubMed
Takagi, Y, Kikuta, K, Nozaki, K, Hashimoto, N. Histological features of middle cerebral arteries from patients treated for moyamoya disease. Neurol Med Chir (Tokyo). 2007;47:1–4.Google Scholar
Kuroda, S, Houkin, K. Moyamoya disease: Current concepts and future perspectives. Lancet Neurol. 2008;7:1056–66.Google Scholar
Chmelova, J, Kolar, Z, Prochazka, V, Curik, R, et al. Moyamoya disease is associated with endothelial activity detected by anti-nestin antibody. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010;154:159–62.Google Scholar
Fukui, M, Kono, S, Sueishi, K, Ikezaki, K. Moyamoya disease. Neuropathology. 2000;20:S61–4.Google Scholar
Takagi, Y, Kikuta, K, Nozaki, K, et al. Expression of hypoxia-inducing factor-1 alpha and endoglin in intimal hyperplasia of the middle cerebral artery of patients with moyamoya disease. Neurosurgery. 2007;60:338–45.Google Scholar
Guo, DC, Papke, CL, Tran-Fadulu, V, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and moyamoya disease, along with thoracic aortic disease. Am J Hum Genet. 2009;84:617–27.Google Scholar
Czabanka, M, Pena-Tapia, P, Schubert, GA, Woitzik, J, Vajkoczy, P, Schmiedek, P. Characterization of cortical microvascularization in adult moyamoya disease. Stroke. 2008;39:1703–9.Google Scholar
Kim, SJ, Son, TO, Kim, KH, et al. Neovascularization precedes occlusion in moyamoya disease: Angiographic findings in 172 pediatric patients. Eur Neurol. 2014;72:299–305.Google Scholar
Ikeda, H, Sasaki, T, Yoshimoto, T, Fukui, M, Arinami, T. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet. 1999;64:533–7.Google Scholar
Inoue, TK, Ikezaki, K, Sasazuki, T, Matsushima, T, Fukui, M. Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol. 2000;15:179–82.CrossRefGoogle ScholarPubMed
Yamauchi, T, Tada, M, Houkin, K et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke. 2000;31:930–5.CrossRefGoogle ScholarPubMed
Sakurai, K, Horiuchi, Y, Ikeda, H, et al. A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Human Genet. 2004;49:278–81.CrossRefGoogle ScholarPubMed
Kamada, F, Aoki, Y, Narisawa, A, et al. A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Human Genet. 2011;56:34–40.CrossRefGoogle ScholarPubMed
Miyatake, S, Miyake, N, Touho, H, et al. Homozygous c.14576 G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology. 2012;78:803–10.Google Scholar
Kim, EH, Yum, MS, Ra, YS, et al. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. J Neurosurg. 2016;124:1221–7.Google Scholar
Sonobe, S, Fujimura, M, Niizuma, K, et al. Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking Rnf213: A susceptibility gene for moyamoya disease. Brain Res. 2014;1552:64–71.CrossRefGoogle Scholar
Kanoke, A, Fujimura, M, Niizuma, K, et al. Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859 K mutation of Rnf213, the susceptibility gene for moyamoya disease. Brain Res. 2015;1624:497–505.CrossRefGoogle Scholar
Ito, A, Fujimura, M, Niizuma, K, et al. Enhanced post-ischemic angiogenesis in mice lacking Rnf213: A susceptibility gene for moyamoya disease. Brain Research. 2015;1594:310–20.CrossRefGoogle ScholarPubMed
Fujimura, M, Sonobe, S, Nishijima, Y, et al. Genetics and biomarkers of moyamoya disease: Significance of RNF213 as a susceptibility gene. J Stroke. 2014;16:65–72.CrossRefGoogle ScholarPubMed
Koizumi, A, Kobayashi, H, Liu, W, et al. P.R4810 K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure. Environ Health Prev Med. 2013;18:121–9.CrossRefGoogle Scholar
Liu, W, Morito, D, Takashima, S, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One. 2011;6:e22542.CrossRefGoogle ScholarPubMed
Cecchi, AC, Guo, D, Ren, Z, et al. RNF213 rare variants in an ethnically diverse population with moyamoya disease. Stroke. 2014;45:3200–7.Google Scholar
Research Committee on the Pathology, Treatment of Spontaneous Occlusion of the Circle of Willis, Health Labour Sciences Research Grant for Research on Measures for Infractable D. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of willis). Neurol Med Chir. 2012;52:245–66.Google Scholar
Kim, SJ, Heo, KG, Shin, HY, et al. Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: A prospective study. Stroke. 2010;41:173–6.CrossRefGoogle ScholarPubMed
Bower, RS, Mallory, GW, Nwojo, M, et al. Moyamoya disease in a primarily white, midwestern US population: Increased prevalence of autoimmune disease. Stroke. 2013;44:1997–9.Google Scholar
Miyamato, STJ, Kim, JS. Moyamoya Disease Oxford: Wiley-Blackwell; 2008.Google Scholar
Czartoski, T, Hallam, D, Lacy, JM, Chun, MR, Becker, K. Postinfectious vasculopathy with evolution to moyamoya syndrome. J Neurol Neurosurg Psychiatry. 2005;76:256–9.Google Scholar
Kumar, AH, Caplice, NM. Clinical potential of adult vascular progenitor cells. Arterioscler Thromb Vasc Biol. 2010;30:1080–7.Google Scholar
Yoshihara, T, Taguchi, A, Matsuyama, T, et al. Increase in circulating CD34-positive cells in patients with angiographic evidence of moyamoya-like vessels. J Cereb Blood Flow Metab. 2008;28:1086–9.CrossRefGoogle ScholarPubMed
Rafat, N, Beck, G, Pena-Tapia, PG, Schmiedek, P, Vajkoczy, P. Increased levels of circulating endothelial progenitor cells in patients with moyamoya disease. Stroke. 2009;40:432–8.Google Scholar
Kim, JH, Jung, JH, Phi, JH, et al. Decreased level and defective function of circulating endothelial progenitor cells in children with moyamoya disease. J Neurosci Res. 2010;88:510–18.Google Scholar
Jung, KH, Chu, K, Lee, ST, et al. Circulating endothelial progenitor cells as a pathogenetic marker of moyamoya disease. J Cereb Blood Flow Metab. 2008;28:1795–803.Google Scholar
Kang, HS, Moon, YJ, Kim, YY, et al. Smooth-muscle progenitor cells isolated from patients with moyamoya disease: Novel experimental cell model. J Neurosurg. 2014;120:415–25.CrossRefGoogle ScholarPubMed
Lee, JY, Moon, YJ, Lee, HO, et al. Deregulation of retinaldehyde dehydrogenase 2 leads to defective angiogenic function of endothelial colony-forming cells in pediatric moyamoya disease. Arterioscler Thromb Vasc Biol. 2015;35:1670–7.Google Scholar
Kang, HS, Kim, JH, Phi, JH, et al. Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry. 2010;81:673–8.Google Scholar
Nanba, R, Kuroda, S, Ishikawa, T, Houkin, K, Iwasaki, Y. Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease. Stroke. 2004;35:2837–42.CrossRefGoogle ScholarPubMed
Park, YS, Jeon, YJ, Kim, HS, et al. The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization. PloS One. 2012;7:e47158.Google Scholar
Kim, SK, Yoo, JI, Cho, BK, et al. Elevation of CRABP-I in the cerebrospinal fluid of patients with moyamoya disease. Stroke. 2003;34:2835–41.Google Scholar
Fujimura, M, Watanabe, M, Narisawa, A, Shimizu, H, Tominaga, T. Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease. Surg Neurol. 2009;72:476–80.CrossRefGoogle ScholarPubMed
Kang, HS, Kim, SK, Cho, BK, et al. Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Neurosurgery. 2006;58:1074–80.Google Scholar
He, J, Wang, R, Zhang, D, et al. Expression of circulating vascular endothelial growth factor-antagonizing cytokines and vascular stabilizing factors prior to and following bypass surgery in patients with moyamoya disease. Exp Ther Med. 2014;8:302–8.Google Scholar
Hoshimaru, M, Takahashi, JA, Kikuchi, H, Nagata, I, Hatanaka, M. Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: An immunohistochemical study. J Neurosurg. 1991;75:267–70.Google Scholar
Park, YS, Jeon, YJ, Kim, HS, et al. The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization. PloS One. 2012;7:e47158.Google Scholar
Wang, X, Zhang, Z, Liu, W, et al. Impacts and interactions of PDGFRB, MMP-3, TIMP-2, and RNF213 polymorphisms on the risk of moyamoya disease in Han Chinese human subjects. Gene. 2013;526:437–42.Google Scholar
Young, AM, Karri, SK, Ogilvy, CS, Zhao, N. Is there a role for treating inflammation in moyamoya disease?: A review of histopathology, genetics, and signaling cascades. Front Neurol. 2013;4:105.CrossRefGoogle Scholar
Kim, SK, Cho, BK, Phi, JH, et al. Pediatric moyamoya disease: An analysis of 410 consecutive cases. Ann Neurol. 2010;68:92–101.Google Scholar
Horn, P, Bueltmann, E, Buch, CV, Schmiedek, P. Arterio-embolic ischemic stroke in children with moyamoya disease. Childs Nerv Syst. 2005;21:104–7.Google Scholar
Suzuki, J, Kodama, N. Moyamoya disease: A review. Stroke. 1983;14:104–9.Google Scholar
Kim, JM, Lee, SH, Roh, JK. Changing ischaemic lesion patterns in adult moyamoya disease. J Neurol Neurosurg Psychiatry. 2009;80:36–40.Google Scholar
Hishikawa, T, Tokunaga, K, Sugiu, K, Date, I. Assessment of the difference in posterior circulation involvement between pediatric and adult patients with moyamoya disease. J Neurosurg. 2013;119:961–5.CrossRefGoogle ScholarPubMed
Cho, HJ, Jung, YH, Kim, YD, et al. The different infarct patterns between adulthood-onset and childhood-onset moyamoya disease. J Neurol Neurosurg Psychiatry. 2011;82:38–40.Google Scholar
Nah, HW, Kwon, SU, Kang, DW, Ahn, JS, Kwun, BD, Kim, JS. Moyamoya disease-related versus primary intracerebral hemorrhage: [corrected] Location and outcomes are different. Stroke. 2012;43:1947–50.CrossRefGoogle ScholarPubMed
Kikuta, K, Takagi, Y, Nozaki, K, et al. The presence of multiple microbleeds as a predictor of subsequent cerebral hemorrhage in patients with moyamoya disease. Neurosurgery. 2008;62:104–111.Google Scholar
Mori, N, Miki, Y, Kikuta, K, et al. Microbleeds in moyamoya disease: Susceptibility-weighted imaging versus T2*-weighted imaging at 3 tesla. Invest Radiol. 2008;43:574–9.Google Scholar
Sun, W, Yuan, C, Liu, W, et al. Asymptomatic cerebral microbleeds in adult patients with moyamoya disease: A prospective cohort study with 2 years of follow-up. Cerebrovasc Dis. 2013;35:469–75.Google Scholar
Ikezaki, K, Matsushima, T, Kuwabara, Y, et al. Cerebral circulation and oxygen metabolism in childhood moyamoya disease: A perioperative positron emission tomography study. J Neurosurg. 1994;81:843–50.Google Scholar
Hogan, AM, Kirkham, FJ, Isaacs, EB, Wade, AM, Vargha-Khadem, F. Intellectual decline in children with moyamoya and sickle cell anaemia. Dev Med Child Neurol. 2005;47:824–9.Google Scholar
Imaizumi, C, Imaizumi, T, Osawa, M, Fukuyama, Y, Takeshita, M. Serial intelligence test scores in pediatric moyamoya disease. Neuropediatrics. 1999;30:294–9.CrossRefGoogle ScholarPubMed
Seol, HJ, Wang, KC, Kim, SK, Hwang, YS, Kim, KJ, Cho, BK. Headache in pediatric moyamoya disease: Review of 204 consecutive cases. J Neurosurg. 2005;103:439–42.Google Scholar
Park-Matsumoto, YC, Tazawa, T, Shimizu, J. Migraine with aura-like headache associated with moyamoya disease. Acta Neurol Scand. 1999;100:119–21.Google Scholar
Baik, JS, Lee, MS. Movement disorders associated with moyamoya disease: A report of 4 new cases and a review of literatures. Mov Disord. 2010;25:1482–6.Google Scholar
Acker, G, Goerdes, S, Schneider, UC, et al. Distinct clinical and radiographic characteristics of moyamoya disease amongst European Caucasians. Eur J Neurol. 2015;22:1012–17.Google Scholar
Kim, JE, Jeon, JS. An update on the diagnosis and treatment of adult moyamoya disease taking into consideration of controversial issues. Neurol Res. 2014;36:407–16.Google Scholar
Yamada, I, Suzuki, S, Matsushima, Y. Moyamoya disease: Comparison of assessment with MR angiography and MR imaging versus conventional angiography. Radiology. 1995;196:211–18.Google Scholar
Kaku, Y, Morioka, M, Ohmori, Y, et al. Outer-diameter narrowing of the internal carotid and middle cerebral arteries in moyamoya disease detected on 3D constructive interference in steady-state MR image: Is arterial constrictive remodeling a major pathogenesis? Acta Neurochir (Wien). 2012;154:2151–7.Google Scholar
Yuan, M, Liu, ZQ, Wang, ZQ, et al. High-resolution MR imaging of the arterial wall in moyamoya disease. Neurosci Lett. 2015;584:77–82.CrossRefGoogle ScholarPubMed
Ryoo, S, Cha, J, Kim, SJ, et al. High-resolution magnetic resonance wall imaging findings of moyamoya disease. Stroke. 2014;45:2457–60.Google Scholar
Kurokawa, T, Tomita, S, Ueda, K, et al. Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children. Pediatr Neurol. 1985;1:274–7.Google Scholar
Hallemeier, CL, Rich, KM, Grubb, RL Jr., et al. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke. 2006;37:1490–6.Google Scholar
Kim, T, Oh, CW, Kwon, OK, et al. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia. J Neurosurg. 2016;124:1788–93.CrossRefGoogle ScholarPubMed
Fukui, M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (“moyamoya” disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg. 1997;99:S238–240.Google Scholar
Karasawa, J, Kikuchi, H, Furuse, S, Kawamura, J, Sakaki, T. Treatment of moyamoya disease with STA–MCA anastomosis. J Neurosurg. 1978;49:679–88.CrossRefGoogle ScholarPubMed
Fujimura, M, Tominaga, T. Lessons learned from moyamoya disease: Outcome of direct/indirect revascularization surgery for 150 affected hemispheres. Neurol Med Chir. 2012;52:327–32.CrossRefGoogle ScholarPubMed
Bang, JS, Kwon, OK, Kim, JE, et al. Quantitative angiographic comparison with the OSIRIS program between the direct and indirect revascularization modalities in adult moyamoya disease. Neurosurgery. 2012;70:625–32.Google Scholar
Guzman, R, Lee, M, Achrol, A, et al. Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg. 2009;111:927–35.Google Scholar
Mesiwala, AH, Sviri, G, Fatemi, N, Britz, GW, Newell, DW. Long-term outcome of superficial temporal artery–middle cerebral artery bypass for patients with moyamoya disease in the US. Neurosurg Focus. 2008;24:E15.CrossRefGoogle ScholarPubMed
Miyamoto, S, Akiyama, Y, Nagata, I, Karasawa, J, Nozaki, K, Hashimoto, N, et al. Long-term outcome after STA–MCA anastomosis for moyamoya disease. Neurosurg Focus. 1998;5:e5.Google Scholar
Amin-Hanjani, S, Du, X, Mlinarevich, N, Meglio, G, Zhao, M, Charbel, FT. The cut flow index: An intraoperative predictor of the success of extracranial–intracranial bypass for occlusive cerebrovascular disease. Neurosurgery. 2005;56:75–85.Google ScholarPubMed
Han, JS, Abou-Hamden, A, Mandell, DM, et al. Impact of extracranial–intracranial bypass on cerebrovascular reactivity and clinical outcome in patients with symptomatic moyamoya vasculopathy. Stroke. 2011;42:3047–54.Google Scholar
Matsushima, T, Fukui, M, Kitamura, K, et al. Encephalo-duro-arterio synangiosis in children with moyamoya disease. Acta Neurochir. 1990;104:96–102.Google Scholar
Bao, XY, Duan, L, Yang, WZ, et al. Clinical features, surgical treatment, and long-term outcome in pediatric patients with moyamoya disease in China. Cerebrovascular Dis. 2015;39:75–81.Google Scholar
Scott, RM, Smith, JL, Robertson, RL, et al. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg. 2004;100:142–9.Google ScholarPubMed
Bao, XY, Duan, L, Li, DS, et al. Clinical features, surgical treatment and long-term outcome in adult patients with moyamoya disease in China. Cerebrovasc Dis. 2012;34:305–13.Google Scholar
Aoki, N. Cerebrovascular bypass surgery for the treatment of moyamoya disease: Unsatisfactory outcome in the patients presenting with intracranial hemorrhage. Surg Neurol. 1993;40:372–7.Google Scholar
Liu, X, Zhang, D, Shuo, W, et al. Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease. J Neurol Neurosurg Psychiatry. 2013;84:258–65.Google Scholar
Ahn, JH, Wang, KC, Phi, JH, et al. Hemorrhagic moyamoya disease in children: Clinical features and surgical outcome. Childs Nerv Syst. 2012;28:237–45.Google Scholar
Miyamoto, S, Yoshimoto, T, Hashimoto, N, et al. Effects of extracranial–intracranial bypass for patients with hemorrhagic moyamoya disease: Results of the Japan adult moyamoya trial. Stroke. 2014;45:1415–21.Google Scholar
Kazumata, K, Ito, M, Tokairin, K, et al. The frequency of postoperative stroke in moyamoya disease following combined revascularization: A single-university series and systematic review. J Neurosurg. 2014;121:432–40.CrossRefGoogle ScholarPubMed
Funaki, T, Takahashi, JC, Takagi, Y, et al. Unstable moyamoya disease: Clinical features and impact on perioperative ischemic complications. J Neurosurg. 2015;122:400–7.Google Scholar
Choi, H, Lee, JY, Phi, JH, et al. Postoperative epidural hematoma covering the galeal flap in pediatric patients with moyamoya disease: Clinical manifestation, risk factors, and outcomes. J Neurosurg Pediatr. 2013;12:181–6.Google Scholar
Fujimura, M, Kaneta, T, Mugikura, S, Shimizu, H, Tominaga, T. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery–middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol. 2007;67:273–82.Google Scholar
Fujimura, M, Shimizu, H, Inoue, T, Mugikura, S, Saito, A, Tominaga, T. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial–intracranial bypass for moyamoya disease: Comparative study with non-moyamoya patients using n-isopropyl-p-[(123)i]iodoamphetamine single-photon emission computed tomography. Neurosurgery. 2011;68:957–64.Google Scholar
Uchino, H, Kuroda, S, Hirata, K, et al. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: A serial single photon emission CT/positron emission tomography study. Stroke. 2012;43:2610–16.Google Scholar
Hashikata, H, Liu, W, Mineharu, Y, et al. Current knowledge on the genetic factors involved in moyamoya disease. Brain Nerve. 2008;60:1261–9.Google Scholar
Fujimura, M, Mugikura, S, Kaneta, T, Shimizu, H, Tominaga, T. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery–middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol. 2009;71:442–7.Google ScholarPubMed
Katsuta, T, Inoue, T, Arakawa, S, Uda, K. Cutaneous necrosis after superficial temporal artery-to-middle cerebral artery anastomosis: Is it predictable or avoidable? Neurosurgery. 2001;49:879–82.Google Scholar
Takanari, K, Araki, Y, Okamoto, S, Sato, H, Yagi, S, Toriyama, K, et al. Operative wound-related complications after cranial revascularization surgeries. J Neurosurg. 2015;123:1145–50.Google Scholar
Kim, SH, Kwon, OK, Jung, CK, et al. Endovascular treatment of ruptured aneurysms or pseudoaneurysms on the collateral vessels in patients with moyamoya disease. Neurosurgery. 2009;65:1000–4.Google Scholar
Daou, B, Chalouhi, N, Tjoumakaris, S, Rosenwasser, RH, Jabbour, P. Onyx embolization of a ruptured aneurysm in a patient with moyamoya disease. J Clin Neurosci. 2015;22:1693–6.Google Scholar
Chalouhi, N, Tjoumakaris, S, Gonzalez, LF, et al. Onyx embolization of a ruptured lenticulostriate artery aneurysm in a patient with moyamoya disease. World Neurosurg. 2013;80:e437-410.Google Scholar
Khan, N, Dodd, R, Marks, MP, et al. Failure of primary percutaneous angioplasty and stenting in the prevention of ischemia in moyamoya angiopathy. Cerebrovasc Dis. 2011;31:147–53.Google Scholar
Kim, T, Kwon, OK, Oh, CW, et al. Intracranial stenting using a drug-eluting stent for moyamoya disease involving supraclinoid ICA: A case report. Neurol Med Chir (Tokyo). 2014;54:136–8.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×